Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL130870 | 1.00 | PEPD (0.43) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL34169 | 1.00 | PEPD (0.43) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL10578737 | 1.00 | PEPD (0.43) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL10739888 | 0.98 | PEPD (0.42) | PEPDALDH1A1LMNATP53CYP3A4 | |
| Bicarbonate SCHEMBL8981886 | 0.98 | ALDH1A1 (0.46) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL9663237 | 0.98 | PEPD (0.42) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL11660179 | 0.98 | PEPD (0.42) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL7031195 | 0.98 | PEPD (0.42) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL5525138 | 0.95 | PEPD (0.48) | PEPDALDH1A1LMNATP53CYP3A4 | |
| SCHEMBL336245 | 0.95 | PEPD (0.48) | PEPDALDH1A1LMNATP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313672-A1 | Method for Preparing Lignocellulose Nanofibril and Composite Materials Reinforced Therewith | ZHEJIANG UNIVERSITY (CN) | 2025-10-09 | — | — | US | claimed |
| EP-4446385-A1 | METHODS FOR PREPARING LIGNIN-CONTAINING CELLULOSE NANOFIBRIL AND COMPOSITE MATERIAL REINFORCED WITH SAME | Zhejiang University (CN) | 2024-10-16 | — | — | EP | claimed |
| US-12110390-B2 | Solid dispersion, preparation method therefor, chain-extended polyurethane using same, and epoxy resin composition comprising same | SAMYANG CORPORATION (KR) | 2024-10-08 | — | — | US | claimed |
| WO-2024138534-A1 | METHODS FOR PREPARING LIGNIN-CONTAINING CELLULOSE NANOFIBRIL AND COMPOSITE MATERIAL REINFORCED WITH SAME | 浙江大学 | 2024-07-04 | — | — | WO | claimed |
| CN-112351967-B | Process for preparing high purity cis-cyclohexane-1,2-dicarboxylic acid salts | 美利肯公司 | 2023-08-22 | — | — | CN | claimed |
| CN-115926397-A | Method for preparing degradable nanocellulose reinforced composite materials | 浙江大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115819630-A | Method for preparing high-charge-capacity nanocellulose | 浙江大学衢州研究院 | 2023-03-21 | — | — | CN | claimed |
| CN-115707700-A | Perospirone hydrochloride isomer impurity and preparation method and application thereof | 四川科瑞德制药股份有限公司 | 2023-02-21 | — | — | CN | claimed |
| CN-114057992-A | Resin composition for carbon fiber molding | 上纬新材料科技股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-113661222-A | Degradable urethane and urethane-urea systems | 朗盛公司 | 2021-11-16 | — | — | CN | claimed |
| US-20060270757-A1 | Phase change inks | XEROX CORPORATION | 2006-11-30 | — | — | US | claimed |
| US-7094812-B2 | Colorant compositions | XEROX CORPORATIONS (US) | 2006-08-22 | — | — | US | claimed |
| US-7034185-B2 | Colorant precursor compositions | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20050272902-A1 | Colorant compositions | XEROX CORPORATION | 2005-12-08 | — | — | US | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215022-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215022-A1 | Colorant compositions | ARSA, TST, IK | PEPD 4025/4885ALDH1A1 1311/4885LMNA 2953/4885 |
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | PEPD 4389/4885ALDH1A1 199/4885LMNA 599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.